TFX peer analysis
Teleflex (TFX) against its competitors: price, today's move, 1-year return and market value side by side.
TFX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALKS Alkermes | $44.99 | -0.77% | 45.98% | $7.61B |
| ARWR Arrowhead | $59.76 | -0.23% | 41.24% | $8.46B |
| BLCO Bausch + Lomb | $20.02 | 0.10% | 32.23% | – |
| CRSP CRISPR Therapeutics | $50.22 | -2.33% | -17.81% | $4.97B |
| KRYS Krystal Biotech | $283.50 | -14.68% | 49.94% | $9.84B |
| MMSI Merit Medical | $84.62 | -1.88% | 1.90% | $5.17B |
| PCVX Vaxcyte | $60.80 | -1.98% | 35.87% | $9.76B |
| PTCT PTC Therapeutics | $60.82 | 1.42% | -10.70% | $5.01B |
| STVN Stevanato | $19.38 | -4.25% | -22.29% | – |
| TGTX TG Therapeutics | $60.55 | -1.03% | 77.98% | $9.36B |
| TFX Teleflex | $140.71 | 0.67% | 12.71% | $5.92B |
- TFX's peers: ALKS (Alkermes), ARWR (Arrowhead), BLCO (Bausch + Lomb), CRSP (CRISPR Therapeutics), KRYS (Krystal Biotech), MMSI (Merit Medical), PCVX (Vaxcyte), PTCT (PTC Therapeutics).
Updated 2026-11-02 17:54 UTC